Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales for the second quarter of fiscal 2026.
- In Q2, net sales increased 8.8% year-over-year to $79.4 million; Med Tech sales grew 13% to $35.7 million
- At $43.8 million, Med Device sales were up 5.6% in Q2, compared to $41.3 million in the prior-year period
- AngioDynamics incurred a net loss of $6.4 million or $0.15 per share in Q2, vs. a loss of $10.7 million or $0.26 per share last year
- Excluding special items, on an adjusted basis, the company reported break-even for the quarter, compared to a loss of $0.04 per share in Q2 2025
- Adjusted EBITDA, excluding one-off items, was $5.9 million, compared to $3.1 million in the second quarter of 2025
- The management said it continues to expect to be cash flow positive in the full fiscal year 2026
- The company raised its FY26 net sales guidance to $312-314 million from the earlier outlook of $308-313 million
- It expects a loss per share in the range of $0.33-0.23 for FY26, on an adjusted basis, which is unchanged from the prior guidance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Citigroup set to report Q4 2025 earnings. Here’s what to expect
Citigroup Inc. (NYSE: C) has undergone a sweeping transformation in recent years, emerging as a more streamlined and profitable financial institution. The bank's performance in recent quarters has underscored the
Home Depot (HD), Lowe’s (LOW): Home improvement pressures not expected to abate soon
Home improvement retailers Home Depot (NYSE: HD) and Lowe’s Companies, Inc. (NYSE: LOW) have been facing a challenging operating environment for a while now. The companies have been battling macroeconomic
INTC Stock: Where does Intel stand in the semiconductor race?
Intel Corporation (NASDAQ: INTC) is working to regain dominance in the semiconductor market, while evolving from an integrated chipmaker into a global foundry player. The turnaround plan involves massive capital
